Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marietta Kollars

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|October 25, 2008
Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimerSabine Eichinger, Gregor Hron, Marietta Kollars, et al.
Plos One|December 15, 2012
Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort studyLudwig Traby, Marietta Kollars, Lisbeth Eischer, et al.
JAMA|July 27, 2006
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generationGregor Hron, Marietta Kollars, Bernd R Binder, et al.
The American Journal of the Medical Sciences|March 30, 2021
MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary ReportJessica Gabler, José Basílio, Oskar Steinbrecher, et al.
European Journal of Clinical Investigation|May 12, 2010
Low dose acetylsalicylic acid and shedding of microparticles in vivo in humansBarbara Lubsczyk, Marietta Kollars, Gregor Hron, et al.
Frontiers in Pharmacology|December 29, 2022
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjectsTeresa L Krammer, Marietta Kollars, Paul A Kyrle, et al.
American Journal of Obstetrics and Gynecology|July 6, 2010
ProCGlobal and endogenous thrombin potential during pregnancyGregor Hron, Paul A Kyrle, Alexandra Kaider, et al.
Thrombosis and Haemostasis|December 8, 2007
Prediction of recurrent venous thromboembolism by measuring ProC GlobalSabine Eichinger, Gregor Hron, Mirko Hirschl, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis and Haemostasis|November 8, 2005
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolismMatthias Hoke, Paul A Kyrle, Erich Minar, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|October 25, 2008
Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimerSabine Eichinger, Gregor Hron, Marietta Kollars, et al.
Plos One|December 15, 2012
Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort studyLudwig Traby, Marietta Kollars, Lisbeth Eischer, et al.
JAMA|July 27, 2006
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generationGregor Hron, Marietta Kollars, Bernd R Binder, et al.
The American Journal of the Medical Sciences|March 30, 2021
MicroRNA Signatures in Plasma of Patients With Venous Thrombosis: A Preliminary ReportJessica Gabler, José Basílio, Oskar Steinbrecher, et al.
European Journal of Clinical Investigation|May 12, 2010
Low dose acetylsalicylic acid and shedding of microparticles in vivo in humansBarbara Lubsczyk, Marietta Kollars, Gregor Hron, et al.
Frontiers in Pharmacology|December 29, 2022
Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjectsTeresa L Krammer, Marietta Kollars, Paul A Kyrle, et al.
American Journal of Obstetrics and Gynecology|July 6, 2010
ProCGlobal and endogenous thrombin potential during pregnancyGregor Hron, Paul A Kyrle, Alexandra Kaider, et al.
Thrombosis and Haemostasis|December 8, 2007
Prediction of recurrent venous thromboembolism by measuring ProC GlobalSabine Eichinger, Gregor Hron, Mirko Hirschl, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis and Haemostasis|November 8, 2005
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolismMatthias Hoke, Paul A Kyrle, Erich Minar, et al.
Pageof 2